GRCE Competitors & Alternatives
Compare Grace Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
GRCE
Main Stock$1.81
Tradestie Score
37
Market Cap
$42.45M
Analyst Upside
+223.3%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.36
|
$133.50M | - | 41 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.61
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$29.54
|
$110.20M | - | 35 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$3.98
|
$107.83M | - | 39 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.11
|
$84.52M | - | 47 | Compare |
|
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
|
$0.68
|
$83.60M | - | 47 | Compare |
|
UNCY
Unicycive Therapeutics, Inc. Common Stock
|
$3.55
|
$78.68M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.84
|
$67.94M | - | 48 | Compare |
|
OSTX
OS Therapies Incorporated
|
$0.75
|
$63.29M | - | 41 | Compare |
|
NEUP
Neuphoria Therapeutics Inc. Common Stock
|
$2.55
|
$26.04M | - | 42 | Compare |
More GRCE Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry